Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Molina Healthcare, Inc.    MOH

MOLINA HEALTHCARE, INC.

(MOH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Molina Healthcare, Inc. : Attractive price levels

09/29/2020 | 09:53am EST
long trade
Target price hit
Entry price : 163.955$ | Target : 194$ | Stop-loss : 147.5$ | Potential : 18.33%
Molina Healthcare, Inc. shares have returned to important technical levels around 149.8 USD based on weekly price data. The timing seems attractive to be a buyer of this stock.
Investors have an opportunity to buy the stock and target the $ 194.
Molina Healthcare, Inc. : Molina Healthcare, Inc. : Attractive price levels
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 149.8 USD in weekly data.
  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.37 for the 2020 fiscal year.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The stock is in a well-established, long-term rising trend above the technical support level at 149.8 USD

Weaknesses
  • The group usually releases earnings worse than estimated.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 19 450 M - -
Net income 2020 694 M - -
Net cash 2020 2 123 M - -
P/E ratio 2020 19,2x
Yield 2020 -
Capitalization 13 231 M 13 231 M -
EV / Sales 2020 0,57x
EV / Sales 2021 0,40x
Nbr of Employees 10 000
Free-Float 99,3%
Upcoming event on MOLINA HEALTHCARE, INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 235,58 $
Last Close Price 223,12 $
Spread / Highest target 27,7%
Spread / Average Target 5,59%
Spread / Lowest Target -13,1%
EPS Revisions
Managers and Directors
NameTitle
Joseph M. Zubretsky President, Chief Executive Officer & Director
Dale B. Wolf Chairman
Thomas L. Tran Chief Financial Officer & Treasurer
Jason Dees Chief Medical Officer
Ronna E. Romney Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
MOLINA HEALTHCARE, INC.4.91%13 231
UNITEDHEALTH GROUP1.23%329 763
CIGNA CORPORATION7.32%80 714
ANTHEM, INC.-2.18%78 116
HUMANA INC.1.06%53 622
CENTENE CORPORATION2.47%35 663